Efficacy measures: Surrogates or clinical outcomes?

被引:22
作者
Blue, JW
Colburn, WA
机构
[1] HARRIS LABS INC, PHOENIX, AZ 85040 USA
[2] BAXTER HEALTHCARE CORP, ROUND LAKE, IL 60073 USA
关键词
D O I
10.1002/j.1552-4604.1996.tb04249.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:767 / 770
页数:4
相关论文
共 14 条
[1]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[2]   Utility of illness severity scoring for prediction of prolonged surgical critical care [J].
Barie, PS ;
Hydo, LJ ;
Fischer, E .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1996, 40 (04) :513-519
[3]  
Benowitz S, 1996, SCIENTIST, V10, P1
[4]  
BENOWITZ S, 1996, SCIENTIST, V10, P7
[5]  
BENOWITZ S, 1996, SCIENTIST, V10, P6
[6]   SURROGATE MARKERS AND CLINICAL-PHARMACOLOGY [J].
COLBURN, WA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (05) :441-442
[7]   SURROGATE END-POINTS [J].
ELLENBERG, SS .
BRITISH JOURNAL OF CANCER, 1993, 68 (03) :457-459
[8]  
Fleming TR, 1996, DRUG INF J, V30, P545
[9]   SURROGATE BIOCHEMICAL MARKERS - PRECISE MEASUREMENT FOR STRATEGIC DRUG AND BIOLOGICS DEVELOPMENT [J].
LEE, JW ;
HULSE, JD ;
COLBURN, WA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (05) :464-470
[10]   MULTIPLE ORGAN DYSFUNCTION SCORE - A RELIABLE DESCRIPTOR OF A COMPLEX CLINICAL OUTCOME [J].
MARSHALL, JC ;
COOK, DJ ;
CHRISTOU, NV ;
BERNARD, GR ;
SPRUNG, CL ;
SIBBALD, WJ .
CRITICAL CARE MEDICINE, 1995, 23 (10) :1638-1652